77 FR 21 pgs. 5026-5027 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
Type: NOTICEVolume: 77Number: 21Pages: 5026 - 5027
FR document: [FR Doc. 2012-2143 Filed 1-31-12; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Identifying Reasons for Racial/Ethnic Disparities with Completing the HPV Vaccine Series among Adolescent Females, IP12-004, and Intervention Study to Increase Use of Standing Orders Programs for Vaccinating Adults in Physician Office Settings, IP12-005, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 8 a.m.-5 p.m., May 3, 2012 (Closed).
Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997-1100.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to "Identifying Reasons for Racial/Ethnic Disparities with Completing the HPV Vaccine Series among Adolescent Females, FOA IP12-004; and Intervention Study to Increase Use of Standing Orders Programs for Vaccinating Adults in Physician Office Settings, FOA IP12-005."
Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease Control and Prevention.
[FR Doc. 2012-2143 Filed 1-31-12; 8:45 am]
BILLING CODE 4163-18-P